324 related articles for article (PubMed ID: 2971554)
1. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
Bouhelal R; Smounya L; Bockaert J
Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
[TBL] [Abstract][Full Text] [Related]
2. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
5. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):285-92. PubMed ID: 2572975
[TBL] [Abstract][Full Text] [Related]
7. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies.
Waeber C; Schoeffter P; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):479-85. PubMed ID: 2533324
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat.
Mørk A; Geisler A
Eur J Pharmacol; 1990 Jan; 175(3):237-44. PubMed ID: 2138981
[TBL] [Abstract][Full Text] [Related]
10. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
Schoeffter P; Waeber C; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):602-8. PubMed ID: 3216894
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
Devivo M; Maayani S
Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes.
Shenker A; Maayani S; Weinstein H; Green JP
Mol Pharmacol; 1987 Apr; 31(4):357-67. PubMed ID: 2952874
[TBL] [Abstract][Full Text] [Related]
13. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
Markstein R; Hoyer D; Engel G
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
[TBL] [Abstract][Full Text] [Related]
15. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
16. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
[TBL] [Abstract][Full Text] [Related]
17. Pertussis toxin attenuates 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat hippocampal membranes.
Okada F; Tokumitsu Y; Nomura Y
J Neurochem; 1989 May; 52(5):1566-9. PubMed ID: 2523468
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
Schoeffter P; Hoyer D
J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
[TBL] [Abstract][Full Text] [Related]
19. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?
Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanisms involved in the negative coupling between serotonin 5-HT1A receptors and carbachol-stimulated phosphoinositide turnover in the rat hippocampus.
Claustre Y; Benavides J; Scatton B
J Neurochem; 1991 Apr; 56(4):1276-85. PubMed ID: 1848278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]